BioXcel Therapeutics Ownership | Who Owns BioXcel Therapeutics?
BioXcel Therapeutics Ownership Summary
BioXcel Therapeutics is owned by 1.27% institutional investors, 17.22% insiders, and 81.51% retail investors. Armistice capital is the largest institutional shareholder, holding 10.18% of BTAI shares. BSO Bio Santé C is the top mutual fund, with 2.26% of its assets in BioXcel Therapeutics shares.
BTAI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BioXcel Therapeutics | 1.27% | 17.22% | 81.51% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Armistice capital | 4.32M | 10.18% | $1.61M |
| Ubs group | 1.28M | 3.01% | $477.56K |
| Vanguard group | 1.19M | 2.80% | $444.11K |
| Blackrock | 440.69K | 1.43% | $564.08K |
| Blackrock funding, inc. /de | 380.61K | 0.90% | $142.31K |
| Geode capital management | 311.96K | 0.74% | $116.67K |
| Charles schwab investment management | 203.62K | 0.66% | $260.63K |
| Northern trust | 194.95K | 0.63% | $249.54K |
| Morgan stanley | 116.56K | 0.38% | $149.20K |
| Goldman sachs group | 98.97K | 0.32% | $126.68K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Armistice capital | 4.32M | 0.02% | $1.61M |
| Point72 asia (singapore) pte. | 15.94K | 0.00% | $5.96K |
| Diversify wealth management | 40.00K | 0.00% | $15.09K |
| Arete wealth advisors | 40.50K | 0.00% | $15.00K |
| Two sigma securities | 17.32K | 0.00% | $6.47K |
| Virtu financial | 16.98K | 0.00% | $6.00K |
| Engineers gate manager lp | 11.98K | 0.00% | $4.48K |
| Parkside financial bank & trust | 1.80K | 0.00% | $674.00 |
| Washington trust advisors | 2.57K | 0.00% | $962.00 |
| Ubs group | 1.28M | 0.00% | $477.56K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | 4.32M | 0.02% | 4.32M |
| Ubs group | 1.28M | 0.00% | 1.26M |
| Goldman sachs group | 98.97K | - | 76.20K |
| Squarepoint ops | 72.05K | - | 48.34K |
| Bank of america corp /de/ | 73.43K | - | 26.06K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | - | - | -2.21M |
| Blackrock | 440.69K | - | -887.38K |
| Ameriprise financial | - | - | -579.16K |
| Beacon pointe advisors | - | - | -301.74K |
| Bank of new york mellon | - | - | -123.08K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Lpl financial | 18.40K | - | 18.40K | $23.55K |
| Two sigma securities | 17.32K | 0.00% | 17.32K | $6.47K |
| Aqr capital management | 14.36K | - | 14.36K | $18.38K |
| Cubist systematic strategies | 4.26K | - | 4.26K | $1.59K |
| Macquarie group | 1.05K | - | 1.05K | $1.35K |
Sold Out
| Holder | Change |
|---|---|
| Citigroup | -3.00 |
| Nelson, van denburg & campbell wealth management group | -4.00 |
| New york state common retirement fund | -273.00 |
| Massmutual trust co fsb/adv | -297.00 |
| Russell investments group | -344.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 13 | -74.00% | 537,273 | -82.68% | 1 | 2.37% | 4 | -63.64% | 6 | -77.78% |
| Sep 30, 2024 | 50 | -33.33% | 3,102,869 | -68.25% | 7 | 0.73% | 12 | -72.73% | 27 | 50.00% |
| Jun 30, 2024 | 75 | -2.60% | 9,773,375 | 5.76% | 31 | 3.15% | 44 | 51.72% | 18 | -28.00% |
| Mar 31, 2024 | 77 | - | 9,241,283 | -1.19% | 31 | 3.11% | 29 | -14.71% | 25 | -13.79% |
| Dec 31, 2023 | 77 | -14.44% | 9,352,370 | -8.29% | 31 | 2.62% | 34 | -15.00% | 29 | -9.38% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BSO Bio Santé C | 70.00K | 2.26% | - |
| Vanguard Total Stock Mkt Idx Inv | 55.39K | 1.73% | - |
| Fidelity Growth Compy Commingled Pl O | 469.48K | 1.15% | -425.27K |
| Vanguard US Total Market Shares ETF | 886.24K | 1.01% | -1.00 |
| Fidelity Growth Company Fund | 353.64K | 0.87% | -248.67K |
| Vanguard Institutional Extnd Mkt Idx Tr | 18.33K | 0.57% | -2.00 |
| Fidelity Growth Company K6 | 163.94K | 0.40% | -132.22K |
| Fidelity Series Growth Company | 88.26K | 0.22% | -63.60K |
| Fidelity Extended Market Index | 10.97K | 0.20% | -3.00 |
| State St US Extended Mkt Indx NL Cl C | 6.10K | 0.20% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 16, 2024 | O'Neill Vincent | See Remarks | Sell | $58.13 |
| Dec 16, 2024 | Mehta Vimal | CEO and President | Sell | $773.36 |
| Dec 16, 2024 | Mehta Vimal | CEO and President | Sell | $357.91 |
| Dec 16, 2024 | Steinhart Richard I | Chief Financial Officer | Sell | $73.80 |
| Dec 16, 2024 | Steinhart Richard I | Chief Financial Officer | Sell | $133.18 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q4 | - | 12 |
| 2024 Q3 | - | 7 |
| 2024 Q2 | - | 19 |
| 2024 Q1 | - | - |
BTAI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools